HAL vs TVRD · P/E 9.3, $19.05B cap vs rev $7.1M
Halliburton Company (HAL) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported TVRD revenue for 2024-12-31 was $7.1M. Net income was -$70.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. TVRD currently screens at market cap $0.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TVRD currently screens at market cap $0.
Not investment advice. Open the HAL and TVRD stock pages for the full models.
Not investment advice.